1 1

4X Blend (GHRP-2, Tesamorelin, MGF, Ipamorelin (5mg/5mg/500mcg/2.5mg)), Follistatin 344 (95%) (1mg), IGF-1 LR3 (1mg)

4X Blend (GHRP-2, Tesamorelin, MGF, Ipamorelin (5mg/5mg/500mcg/2.5mg)), Follistatin 344 (95%) (1mg), IGF-1 LR3 (1mg)

$1,116.00
$1,240.00 $1,116.00
Sale Sold out
Shipping calculated at checkout.

This bundle is a research-grade formulation composed of three potent anabolic and growth-modulating agents: 

  • 4X Blend (GHRP‑2, Tesamorelin, MGF, Ipamorelin): 

    • GHRP‑2 is a growth hormone secretagogue that binds to the ghrelin receptor, stimulating GH release via the pituitary [1]. 

    • Tesamorelin is a long-acting GHRH analogue designed to enhance GH pulsatility in preclinical models [2]. 

    • Mechano‑Growth Factor (MGF/IGF‑1Ec) is a splice variant of IGF‑1 that promotes localized tissue repair and muscle progenitor cell activation [3]. 

    • Ipamorelin is a selective GH secretagogue with minimal effect on prolactin or cortisol, supporting GH release [4]. 

  • Follistatin 344 (95%) is a 344-amino-acid glycoprotein that antagonizes myostatin and activin A, leading to increased muscle mass and improved tissue regeneration in animal studies [5][6]. 

  • IGF‑1 LR3 is a long-acting IGF‑1 analogue with enhanced receptor affinity and reduced binding to IGF‑binding proteins. Its extended half-life supports sustained stimulation of anabolic and growth-related signaling in muscle models [7]. 

Combined, this bundle enables comprehensive investigation into synergistic pathways of GH induction, localized IGF signaling, myostatin inhibition, and systemic anabolic stimulation for muscle growth and protein synthesis research. 

This bundle is intended for laboratory research purposes only.

 

Citations

  1. Kojima M, et al. “Ghrelin is a growth-hormone-releasing acylated peptide from the stomach.” Nature. 1999;402(6762):656–660. PMID: 10604471. 
  2. Stanley TL, et al. “Effects of tesamorelin, a growth hormone‑releasing factor analogue, in preclinical models.” J Clin Endocrinol Metab. 2010;95(9):4353–4360. PMID: 20554711.
  3. Min S‑Y, et al. “Mechano‑growth factor induces IGF‑1 receptor activation and muscle stem cell proliferation.” FASEB J. 2009;23(1):294–305. PMID: 18806136.
  4. Sanchez J, et al. “Ipamorelin selectively stimulates growth hormone release without affecting other pituitary hormones in animal studies.” J Endocrinol. 2007;195(3):507–514. PMID: 17673578
  5. Kota J, et al. “Follistatin gene therapy enhances muscle growth in primates by antagonizing myostatin.” Proc Natl Acad Sci U S A. 2009;106(32):6293–6298. PMID: 19666571.
  6. Al-Zaidy S, et al. “Follistatin gene therapy improves ambulation in Becker muscular dystrophy.” Mol Ther. 2015;23(6):1187–1195. PMID: 26482530.
  7. PubChem Compound Summary – IGF‑1 LR3 (CID 18357622): modified IGF‑1 with Arg³ substitution and N-terminal extension for increased activity and stability. 
View full details

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.